The intermittent vacuum therapy (IVT) is a treatment conducted in case of venous and arterial issues as well as in rehabilitation (after sports injuries [1] and vascular complaints). With the aid of normal and low pressure, it should enable to control venous reflux, enhance lymphatic flow [2] and improve blood flow in periphery and muscles.

Intravitreal injections are among some of the most common procedures in ophthalmology. Among the indications include diabetic retinopathy, neovascular age-related macular degeneration, retinal vein occlusion with macular edema, and choroidal neovascularization from various etiologies.

The most important pillar of High Care ® Medial is the proven Intermittent Vacuum Therapy (IVT) which is conducted by means of the VACUMED ® device (variants: VACUSPORT ®. This unique low pressure treatment was developed in a collaboration of Weyergans and the institute of the German Society of Aerospace Medicine.

Intravitreal (IVT) administration is currently the standard of care for administration of anti-VEGF agents to treat wet age-related macular degeneration (wet AMD). In addition to wet AMD, IVT injections are also administered to treat ocular conditions such as branched and central vein occlusion, diabetic macular edema (DME), and uveitis.

2023年1月13日 · Intravitreal (IVT) injections are the mainstay of treatment for neovascular age-related macular degeneration (nAMD), diabetic macular edema and macular edema due to veinous occlusive disease. Patients in a survey study completed a questionnaire to grade the distress score felt during stages of IVT injection procedure.

2023年3月11日 · In this article, we will highlight technical challenges associated with IVT product use and administration, and include considerations from both the ophthalmologist’s point-of-view (e.g. selection of needle size, small injection volumes) as well as from the patient’s perspective.

Purpose : To evaluate the safety & efficacy of a novel cooling device capable of achieving ocular surface anesthesia within 10 seconds prior to intravitreal injection (IVT). Methods : Results from an ongoing, multicenter, open-label study evaluating repeated cooling anesthesia administrations will be presented (COOL-2; NCT03956797).

2015年5月1日 · The 2014 report identified aspects of IVT injection that have advanced over the past decade. It cites the evidence on which each guideline is based and summarizes the points of discussion among the expert panelists.

Every patient having IVT should have a clear management plan and be under the care of a named consultant ophthalmologist or SAS doctor with autonomous practice rights in this area. Injections may be administered by a trainee doctor under supervision of such an ophthalmologist. Additionally, IVT administration may be delegated by a named consultant

Background Delivery of therapeutic agents via intravitreal (IVT) injections is well established as the mainstay of treatment for many ophthalmic conditions. High demand means that injections are increasingly being delivered either by ophthalmic nurse practitioners (UK) or by ophthalmologists in office-based settings (North America/mainland Europe).